Liraglutide for the treatment of obesity
Obesity and being overweight have become significant global health concerns, and may actually be seen as chronic disease conditions or even as a worldwide epidemic. In addition to the necessary life-style modifications required to effect weight-loss, which constitutes an essential healthcare interve...
Saved in:
| Main Authors: | Elmien Bronkhorst, Natalie Schellack |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2016-05-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/4496 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
First GLP-1 analog liraglutide: the result of clinical trails on efficacy
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01) -
The efficacy of liraglutide-based drugs on the model of induced metabolic syndrome in experimental animals
by: A. A. Andreev-Andrievsky, et al.
Published: (2025-08-01) -
Relative Effectiveness and Safety of the GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists, Semaglutide and Liraglutide in the Treatment of Obese Type 2 Diabetics: A Prospective Observational Cohort Study in Poland
by: Hoffmann K, et al.
Published: (2025-08-01) -
Compare the Decrease in Visceral Adipose Tissue in People with Obesity and Prediabetes vs. Obesity and Type 2 Diabetes Treated with Liraglutide
by: Rosa Nayely Hernández-Flandes, et al.
Published: (2025-07-01) -
Liraglutide Therapy in Obese Patients Alters Macrophage Phenotype and Decreases Their Tumor Necrosis Factor Alpha Release and Oxidative Stress Markers—A Pilot Study
by: Łukasz Bułdak, et al.
Published: (2024-10-01)